Reactive oxygen and nitrogen species during viral infections

References

• Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radical Biol Med 1995;18:775–794.
   PubMed Web of Science ®Google Scholar
• Castro SM, Guerrero-Plata A, Suarez-Real G, Adegboyega PA, Colasurdo GN, Khan AM, et al. Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation. Am J Respir Crit Care Med 2006;174:1361–1369.
   PubMed Web of Science ®Google Scholar
• Garofalo RP, Kolli D, Casola A. Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities. Antioxid Redox Signal 2013;18:186–217.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984;219:1–14.
   PubMed Web of Science ®Google Scholar
• Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992;267:5317–5323.
   PubMed Web of Science ®Google Scholar
• González-Amaro R, García-Monzón C, García-Buey L, Moreno-Otero R, Alonso JL, Yagüe E, et al. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994;179:841–848.
   PubMed Web of Science ®Google Scholar
• Chrobot AM, Szaflarska-Szczepanik A, Drewa G. Antioxidant defense in children with chronic viral hepatitis B and C. Med Sci Monit 2000;6:713–718.
   PubMedGoogle Scholar
• Boudreau HE, Emerson SU, Korzeniowska A, Jendrysik MA, Leto TL. Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress. J Virol 2009;83:12934–12946.
   PubMedGoogle Scholar
• Li Y, Boehning DF, Qian T, Popov VL, Weinman SA. Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2 + uniporter activity. FASEB J 2007;21:2474–2485.
   PubMed Web of Science ®Google Scholar
• Ming-Ju H, Yih-Shou H, Tzy-Yen C, Hui-Ling C. Hepatitis C virus E2 protein induce reactive oxygen species (ROS)-related fibrogenesis in the HSC-T6 hepatic stellate cell line. J Cell Biochem 2011;112:233–243.
   PubMedGoogle Scholar
• Dionisio N, Garcia-Mediavilla MV, Sanchez-Campos S, Majano PL, Benedicto I, Rosado JA, et al. Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes. J Hepatol 2009;50:872–882.
   PubMed Web of Science ®Google Scholar
• Machida K, Cheng KT, Lai CK, Jeng KS, Sung VM, Lai MM. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol 2006;80: 7199–7207.
   PubMedGoogle Scholar
• Paracha UZ, Fatima K, Alqahtani M, Chaudhary A, Abuzenadah A, Damanhouri G, Quadri I. Oxidative stress and hepatitis C virus. Virol J 2013;10:251.
   PubMed Web of Science ®Google Scholar
• Lassoued S, Ben Ameur R, Ayadi W, Gargouri B, Ben Mansour R, Attia H. Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. Mol Cell Biochem 2008;313:179–186.
   PubMed Web of Science ®Google Scholar
• Gruhne B, Sompallae R, Marescotti D, Kamranvar SA, Gastaldello S, Masucci MG. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci U.S.A. 2009; 106:2313–2318.
   PubMedGoogle Scholar
• Aubert M, Chen Z, Lang R, Dang CH, Fowler C, Sloan DD, Jerome KR. The antiapoptotic herpes simplex virus glycoprotein J localizes to multiple cellular organelles and induces reactive oxygen species formation. J Virol 2008; 82:617–629.
   PubMed Web of Science ®Google Scholar
• Zeng D, Zhang T, Zhou S, Hu H, Li J, Huang K, et al. Proteomic analyses of gastric cancer cells treated with vesicular stomatitis virus matrix protein. Protein J 2011;30:308–317.
   PubMed Web of Science ®Google Scholar
• Bhaskar A, Bala J, Varshney A, Yadava P. Expression of measles virus nucleoprotein induces apoptosis and modulates diverse functional proteins in cultured mammalian cells. PLoS One 2011;6:e18765.
   PubMed Web of Science ®Google Scholar
• Claus C, Schönefeld K, Hübner D, Chey S, Reibetanz U, Liebert UG. Activity increase in respiratory chain complexes by rubella virus with marginal induction of oxidative stress. J Virol 2013;87:8481–8492.
   PubMedGoogle Scholar
• Hosakote YM, Komaravelli N, Mautemps N, Liu T, Garofalo RP, Casola A. Antioxidant mimetics modulate oxidative stress and cellular signaling in airway epithelial cells infected with respiratory syncytial virus. Am J Physiol Lung Cell Mol Physiol 2012;303:L991–1000.
   PubMed Web of Science ®Google Scholar
• Hosakote YM, Liu T, Castro SM, Garofalo RP, Casola A. Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes. Am J Respir Cell Mol Biol 2009;41:348–357.
   PubMed Web of Science ®Google Scholar
• Hosakote YM, Jantzi PD, Esham DL, Spratt H, Kurosky A, Casola A, Garofalo RP. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2011;183:1550–1560.
   PubMed Web of Science ®Google Scholar
• Agrawal L, Louboutin JP, Marusich E, Reyes BA, Van Bockstaele EJ, Strayer DS. Dopaminergic neurotoxicity of HIV-1 gp120: reactive oxygen species as signaling intermediates. Brain Res 2010;1306:116–130.
   PubMed Web of Science ®Google Scholar
• Agrawal L, Louboutin JP, Strayer DS. Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications. Virology 2007; 363:462–472.
   PubMed Web of Science ®Google Scholar
• Isaguliants M, Smirnova O, Ivanov AV, Kilpelainen A, Kuzmenko Y, Petkov S, et al. Oxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme’s performance in gene immunization. Hum Vaccin Immunother 2013;9:2111–2119.
   PubMed Web of Science ®Google Scholar
• Porter KM, Sutliff RL. HIV-1, reactive oxygen species, and vascular complications. Free Radic Biol Med 2012;53: 143–159.
   PubMed Web of Science ®Google Scholar
• Silic-Benussi M, Cavallari I, Vajente N, Vidali S, Chieco-Bianchi L, Di Lisa F, et al. Redox regulation of T-cell turnover by the p13 protein of human T-cell leukemia virus type 1: distinct effects in primary versus transformed cells. Blood. 2010;116:54–62.
   PubMedGoogle Scholar
• Takahashi M, Higuchi M, Makokha GN, Matsuki H, Yoshita M, Tanaka Y, et al. HTLV-1 Tax oncoprotein stimulates ROS production and apoptosis in T cells by interacting with USP10. Blood 2013;122:715–725.
   PubMedGoogle Scholar
• Hancock JT, Desikan R, Neill SJ. Role of reactive oxygen species in cell signalling pathways. Biochem Soc Trans 2001;29:345–350.
   PubMed Web of Science ®Google Scholar
• Geller DA, Billiar TR. Molecular biology of nitric oxide synthases. Cancer and Metastasis Rev 1998;17:7–23.
   PubMed Web of Science ®Google Scholar
• Adamson DC, Kopnisky KL, Dawson TM, Dawson VL. Mechanisms and structural determinants of HIV-1 coat protein, gp41-induced neurotoxicity. J Neurosci 1999;19: 64–71.
   PubMed Web of Science ®Google Scholar
• Yu QR, Zhang ZP, Zhang H, Lin HT, Li XM, Bai L, Cai WB. Inducible nitric oxide synthase is involved in the oxidation stress induced by HIV-1 gp120 in human retina pigment epithelial cells. Chin Med J (Engl) 2008;121:2578–2583.
   PubMed Web of Science ®Google Scholar
• Polazzi E, Levi G, Minghetti L. Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures. J Neuropathol Exp Neurol 1999;58:825–831.
   PubMed Web of Science ®Google Scholar
• García-Mediavilla MV, Sánchez-Campos S, González-Pérez P, Gómez-Gonzalo M, Majano PL, López-Cabrera M, et al. Differential contribution of hepatitis C virus NS5A and core proteins to the induction of oxidative and nitrosative stress in human hepatocyte-derived cells. J Hepatol 2005;43:606–613.
   PubMedGoogle Scholar
• Machida K, Cheng KT, Sung VM, Lee KJ, Levine AM, Lai MM. Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol 2004;78:8835–8843.
   PubMed Web of Science ®Google Scholar
• Pindado J, Balsinde J, Balboa MA. TLR3-dependent induction of nitric oxide synthase in RAW 264.7 macrophage-like cells via a cytosolic phospholipase A2/cyclooxygenase-2 pathway. J Immunol 2007;179:4821–4828.
   Google Scholar
• Mgbemena V, Segovia J, Chang TH, Bose S. KLF6 and iNOS regulates apoptosis during respiratory syncytial virus infection. Cell Immunol 2013;283:1–7.
   PubMedGoogle Scholar
• Morris KR, Lutz RD, Bai X, McGibney MT, Cook D, Ordway D, et al. Suppression of IFNgamma+ mycobacterial lipoarabinomannan-induced NO by IL-4 is due to decreased IRF-1 expression. Tuberculosis (Edinb) 2009;89:294–303.
   PubMedGoogle Scholar
• Stempin CC, Dulgerian LR, Garrido VV, Cerban FM. Arginase in parasitic infections: macrophage activation, immunosuppression, and intracellular signals. J Biomed Biotechnol 2010;2010:683485.
   PubMedGoogle Scholar
• Higashimoto Y, Ohata M, Yamagata Y, Iwata T, Masuda M, Ishiguchi T, et al. Effect of the adenovirus E1A gene on nitric oxide production in alveolar epithelial cells. Clin Microbiol Infect 2005;11:644–650.
   PubMedGoogle Scholar
• Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424–C1437.
   PubMed Web of Science ®Google Scholar
• van der Vliet A, Eiserich JP, Shigenaga MK, Cross CE. Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med 1999;160:1–9.
   PubMed Web of Science ®Google Scholar
• van Dalen CJ, Winterbourn CC, Kettle AJ. Mechanism of nitrite oxidation by eosinophil peroxidase: implications for oxidant production and nitration by eosinophils. Biochem J 2006;394(Pt 3):707–713.
   PubMedGoogle Scholar
• Mehlhase J, Grune T. Proteolytic response to oxidative stress in mammalian cells. Biol Chem 2002;383:559–567.
   PubMedGoogle Scholar
• Netzer N, Goodenbour JM, David A, Dittmar KA, Jones RB, Schneider JR, et al. Innate immune and chemically triggered oxidative stress modifies translational fidelity. Nature 2009; 462:522–526.
   PubMed Web of Science ®Google Scholar
• Teoh CY, Davies KJ. Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the ‘PrOxI’ hypothesis. Arch Biochem Biophys 2004; 423:88–96.
   PubMed Web of Science ®Google Scholar
• Graziewicz MA, Day BJ, Copeland WC. The mitochondrial DNA polymerase as a target of oxidative damage. Nucleic Acids Res 2002;30:2817–2824.
   PubMed Web of Science ®Google Scholar
• Akaike T, Okamoto S, Sawa T, Yoshitake J, Tamura F, Ichimori K, et al. 8-Nitroguanosine formation in viral pneumonia and its implication for pathogenesis. Proc Natl Acad Sci USA 2003;100:685–690.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Nakazawa H, Okada K, Umezawa K, Fukuyama N, Koga Y. Nitric oxide mediates murine cytomegalovirus- associated pneumonitis in lungs that are free of the virus. J Clin Invest 1997;100:1822–1830.
   PubMedGoogle Scholar
• Mori I, Liu B, Hossain MJ, Takakuwa H, Daikoku T, Nishiyama Y, et al. Successful protection by amantadine hydrochloride against lethal encephalitis caused by a highly neurovirulent recombinant influenza A virus in mice. Virology 2002;303:287–296.
   PubMedGoogle Scholar
• Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 2005;6:150–166.
   PubMed Web of Science ®Google Scholar
• Toledo JC Jr, Augusto O. Connecting the chemical and biological properties of nitric oxide. Chem Res Toxicol 2012;25:975–989.
   PubMed Web of Science ®Google Scholar
• Aslan M, Ryan TM, Townes TM, Coward L, Kirk MC, Barnes S, et al. Nitric oxide-dependent generation of reactive species in sickle cell disease. actin tyrosine induces defective cytoskeletal polymerization. J Biol Chem 2003; 278:4194–4204.
   PubMed Web of Science ®Google Scholar
• Brown GC, Borutaite V. Nitric oxide, cytochrome c and mitochondria. Biochem Soc Symp 1999;66:17–25.
   PubMedGoogle Scholar
• Li Z, Wu J, Deleo CJ. RNA damage and surveillance under oxidative stress. IUBMB Life 2006;58:581–588.
   PubMed Web of Science ®Google Scholar
• Calmels S, Hainaut P, Ohshima H. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res 1997;57: 3365–3369.
   PubMed Web of Science ®Google Scholar
• Domingo E, Menéndez-Arias L, Holland JJ. RNA virus fitness. Rev Med Virol 1997;7:87–96.
   PubMed Web of Science ®Google Scholar
• Beck MA, Shi Q, Morris VG, Levander OA. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat Med 1995;1:433–436.
   PubMed Web of Science ®Google Scholar
• Beck MA, Kolbeck PC, Rohr LH, Shi Q, Morris VC, Levander OA. Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice. J Nutr 1994; 124:345–348.
   PubMed Web of Science ®Google Scholar
• Domingo E. Rapid evolution of viral RNA genomes. J Nutr 1997;127(5 Suppl):958S–961S.
   Google Scholar
• Zumla A, James DG. Granulomatous infections: etiology and classification. Clin Infect Dis 1996;23:146–158.
   PubMed Web of Science ®Google Scholar
• Croen KD. Evidence for antiviral effect of nitric oxide. inhibition of herpes simplex virus type 1 replication. J Clin Invest 1993;91:2446–2452.
   PubMed Web of Science ®Google Scholar
• Saura M, Zaragoza C, McMillan A, Quick RA, Hohenadi C, Lowenstein JM. An antiviral mechanism of nitric oxide: inhibition of viral protease. Immunity 1999;10:21–28.
   PubMed Web of Science ®Google Scholar
• Akerström S, Gunalan V, Keng CT, Tan YJ, Mirazimi A. Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected. Virology 2009;395:1–9.
   PubMed Web of Science ®Google Scholar
• Akerström S, Mousavi-Jazi M, Klingström J, Leijon M, Lundkvist A, Mirazimi A. Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol 2005;79:1966–1969.
   PubMed Web of Science ®Google Scholar
• Charnsilpa W, Takhampunya R, Endy TP, Mammen MP, Libraty DH, Ubol S. Nitric oxide radical suppresses replication of wild-type dengue 2 viruses in vitro. J Med Virol 2005;77:89–95.
   PubMed Web of Science ®Google Scholar
• Rimmelzwaan GF, Baars MM, de Lijster P, Fouchier RA, Osterhaus AD. Inhibition of influenza virus replication by nitric oxide. J Virol 1999;73:8880–8883.
   PubMedGoogle Scholar
• Hobson L, Everard ML. Persistent of respiratory syncytial virus in human dendritic cells and influence of nitric oxide. Clin Exp Immunol 2008;151:359–366.
   PubMedGoogle Scholar
• Klingström J, Akerström S, Hardestam J, Stoltz M, Simon M, Falk KI, et al. Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virions. Eur J Immunol 2006;36:2649–2657.
   PubMed Web of Science ®Google Scholar
• Zheng S, De BP, Choudhary S, Comhair SA, Goggans T, Slee R, et al. Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis. Immunity 2003;18:619–630.
   PubMed Web of Science ®Google Scholar
• Zhang X, Brunner T, Carter L, Dutton RW, Rogers P, Bradley L, et al. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 1997;185:1837–1849.
   PubMed Web of Science ®Google Scholar
• Chang RH, Feng MH, Liu WH, Lai MZ. Nitric oxide increased interleukin-4 expression in T lymphocytes. Immunology 1997;90:364–369.
   PubMedGoogle Scholar
• Kallmann BA, Malzkorn R, Kolb H. Exogenous nitric oxide modulates cytokine production in human leukocytes. Life Sci 1999;65:1787–1794.
   PubMedGoogle Scholar
• Bauer H, Jung T, Tsikas D, Stichtenoth DO, Frölich JC, Neumann C. Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology 1997;90:205–211.
   PubMed Web of Science ®Google Scholar
• Macphail SE, Gibney CA, Brooks BM, Booth CG, Flanagan BF, Coleman JW. Nitric oxide regulation of human peripheral blood mononuclear cells: critical time dependence and selectivity for cytokine versus chemokine expression. J Immunol 2003;171:4809–4815.
   PubMedGoogle Scholar
• Albina JE, Cui S, Mateo RB, Riecher JS. Nitric oxide- mediated apoptosis in murine peritoneal macrophages. J Immunol 1993;150:5080–5085.
   PubMed Web of Science ®Google Scholar
• Mebmer UK, Ankarcrona M, Nicotera P, Brune B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett 1994;355:23–26.
   PubMed Web of Science ®Google Scholar
• Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, et al. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U.S.A. 1999;96:846–851.
   PubMed Web of Science ®Google Scholar
• Esposito LA, Kokoszka JE, Waymire KG, Cottrell B, MacGregor GR, Wallace DC. Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene. Free Radic Biol Med 2000;28:754–766.
   PubMed Web of Science ®Google Scholar
• Matsugo S, Yan LJ, Han D, Trischler HJ, Packer L. Elucidation of antioxidant activity of alpha-lipoic acid toward hydroxyl radical. Biochem Biophys Res Commun 1995; 208:161–167.
   PubMed Web of Science ®Google Scholar
• Galano A, Alvarez-Idaboy JR. Glutathione: mechanism and kinetics of its non-enzymatic defense action against free radicals. RSC Adv 2011;1:1763–1771.
   Web of Science ®Google Scholar
• Knoops B, Goemaere J, Van der Eecken V, Declercq JP. Peroxiredoxin 5: structure, mechanism, and function of the mammalian atypical 2-Cys peroxiredoxin. Antioxid Redox Signal 2011;15:817–829.
   PubMed Web of Science ®Google Scholar
• Manta B, Hugo M, Ortiz C, Ferrer-Sueta G, Trujillo M, Denicola A. The peroxidase and peroxynitrite reductase activity of human erythrocyte peroxiredoxin 2. Arch Biochem Biophys 2009;484:146–154.
   PubMed Web of Science ®Google Scholar
• Dey N, Liu T, Garofalo RP, Casola A. TAK1 regulates NF-ΚB and AP-1 activation in airway epithelial cells following RSV infection. Virology 2011;418:93–101.
   PubMed Web of Science ®Google Scholar
• Li W, Liu H, Zhou JS, Cao JF, Zhou XB, Choi AM, et al. Caveolin-1 inhibits expression of antioxidant enzymes through direct interaction with nuclear erythroid 2 p45-related factor-2 (Nrf2). J Biol Chem 2012;287:20922–20930.
   PubMed Web of Science ®Google Scholar
• Kesic MJ, Simmons SO, Bauer R, Jaspers I. Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells. Free Radic Biol Med 2011;51:444–453.
   PubMedGoogle Scholar
• Fan X, Staitieh BS, Jensen JS, Mould KJ, Greenberg JA, Joshi PC, et al. Activating the Nrf2-mediated antioxidant response element restores barrier function in the alveolar epithelium of HIV-1 transgenic rats. Am J Physiol Lung Cell Mol Physiol 2013;305:L267–L277.
   PubMed Web of Science ®Google Scholar
• Uchide N, Toyoda H. Antioxidant therapy as a potential approach to severe influenza-associated complications. Molecules 2011;16:2032–2052.
   PubMed Web of Science ®Google Scholar
• Ha HL, Shin HJ, Feitelson MA, Yu DY. Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol 2010;16:6035–6043.
   PubMed Web of Science ®Google Scholar
• Calland N, Dubuisson J, Rouillé Y, Séron K. Hepatitis C virus and natural compounds: a new antiviral approach? Viruses 2012;4:2197–2217.
   PubMed Web of Science ®Google Scholar
• Irlam JH, Visser MM, Rollins NN, Siegfried N. Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst Rev 2010;12:CD003650.
   Google Scholar
• Isanaka S, Mugusi F, Hawkins C, Spiegelman D, Okuma J, Aboud S, et al. Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial. JAMA 2012;308:1535–1544.
   Web of Science ®Google Scholar
• Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012;3:CD007176.
   PubMed Web of Science ®Google Scholar
• Marotta F, Naito Y, Jain S, Lorenzetti A, Soresi V, Kumari A, et al. Is there a potential application of a fermented nutraceutical in acute respiratory illnesses? an in-vivo placebo-controlled, cross-over clinical study in different age groups of healthy subjects. J Biol Regul Homeost Agents 2012;26:285–294.
   PubMedGoogle Scholar